SCHEMBL17201750

SCHEMBL17201750

COc1cc(/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc(OCC=C(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 0.53
TRPA1 O75762 1/20 0.53
MTNR1A P48039 1/20 0.53
TTR P02766 1/20 0.52
CYP1A1 P04798 1/20 0.52
NQO2 P16083 1/20 0.52
CYP1B1 Q16678 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
MYC P01106 1/20 0.52
PTGES O14684 2/20 0.52
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 1/20 0.51
KDM4E B2RXH2 1/20 0.51
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13727654 0.97 APP (0.54) APPTRPA1MTNR1ACYP1A1PTGES
SCHEMBL13727036 0.93 GSK3B (0.51) APPTRPA1MTNR1ATTRCYP1A1
SCHEMBL28440296 0.86 APP (0.61) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL17201746 0.85 APP (0.61) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL17201748 0.85 APP (0.61) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL20684253 0.85 TTR (0.52) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL17208341 0.85 CYP1A1 (0.51) APPCYP1A1ALDH1A1KDM4E
SCHEMBL28447863 0.84 CYP1A1 (0.62) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL38661511 0.84 NQO2 (0.66) APPTTRCYP1A1NQO2CYP1B1
SCHEMBL17201724 0.84 APP (0.60) APPTTRCYP1A1NQO2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634375-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2023-04-25 US disclosed
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC (US) 2022-12-01 US disclosed
US-11352310-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2022-06-07 US disclosed
US-11352310-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2022-06-07 US disclosed
EP-2709975-B1 PRENYLATED HYDROXYSTILBENES KYNAN DUKE IP LLC (US) 2022-01-12 EP disclosed
EP-2709975-B1 PRENYLATED HYDROXYSTILBENES KYNAN DUKE IP LLC (US) 2022-01-12 EP disclosed
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2020-10-22 US disclosed
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2020-10-22 US disclosed
CN-107266297-B Prenylated hydroxystilbenes, pharmaceutical compositions containing the same, use and preparation method thereof 悉尼大学 2020-10-16 CN disclosed
US-10696615-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2020-06-30 US disclosed
US-10696615-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2020-06-30 US disclosed
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2019-06-27 US disclosed
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2019-06-27 US disclosed
US-10196335-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2019-02-05 US disclosed
US-10196335-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2019-02-05 US disclosed
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196335-B2 Prenylated hydroxystilbenes HMGB2, CYP51A1, CYP8B1 APP 1081/4885TRPA1 2463/4885MTNR1A 1627/4885
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 APP 1819/4885TRPA1 4637/4885MTNR1A 1278/4885
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 APP 1819/4885TRPA1 4637/4885MTNR1A 1278/4885
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES HMGB2, CYP51A1, CYP8B1 APP 1081/4885TRPA1 2463/4885MTNR1A 1627/4885
US-10696615-B2 Prenylated hydroxystilbenes HSD11B1, CYP8B1, NR1H2 APP 2321/4885TRPA1 4519/4885MTNR1A 978/4885
US-11352310-B2 Prenylated hydroxystilbenes HSD11B1, HSD3B1, CYP8B1 APP 1819/4885TRPA1 4637/4885MTNR1A 1278/4885
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, CYP8B1, NR1H2 APP 2321/4885TRPA1 4519/4885MTNR1A 978/4885
US-11634375-B2 Prenylated hydroxystilbenes HCLS1, IWS1, UTS2R APP 2779/4885TRPA1 4515/4885MTNR1A 3350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.